tiprankstipranks
Trending News
More News >
Masimo Corp. (MASI)
:MASI
US Market
Advertisement

Masimo (MASI) Stock Forecast & Price Target

Compare
1,233 Followers
See the Price Targets and Ratings of:

MASI Analyst Ratings

Strong Buy
4Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Masimo
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MASI Stock 12 Month Forecast

Average Price Target

$161.00
▲(13.27% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Masimo in the last 3 months. The average price target is $161.00 with a high forecast of $198.00 and a low forecast of $105.00. The average price target represents a 13.27% change from the last price of $142.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"104":"$104","199":"$199","127.75":"$127.8","151.5":"$151.5","175.25":"$175.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":198,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$198.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":161,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$161.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$105.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[104,127.75,151.5,175.25,199],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,140.65,145.06153846153848,149.47307692307692,153.8846153846154,158.29615384615386,162.7076923076923,167.11923076923077,171.53076923076924,175.94230769230768,180.35384615384615,184.76538461538462,189.17692307692306,193.58846153846153,{"y":198,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,140.65,142.2153846153846,143.78076923076924,145.34615384615384,146.91153846153847,148.47692307692307,150.0423076923077,151.6076923076923,153.17307692307693,154.73846153846154,156.30384615384617,157.86923076923077,159.43461538461537,{"y":161,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,140.65,137.90769230769232,135.16538461538462,132.42307692307693,129.68076923076924,126.93846153846154,124.19615384615385,121.45384615384616,118.71153846153847,115.96923076923076,113.22692307692307,110.48461538461538,107.74230769230769,{"y":105,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":134.4,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":144.22,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":171.69,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.3,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.23,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167.61,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163.65,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.03,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.01,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.54,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$198.00Average Price Target$161.00Lowest Price Target$105.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on MASI
Bank of America Securities
Bank of America Securities
$162
Hold
13.97%
Upside
Initiated
11/17/25
Masimo initiated with a Neutral at BofAMasimo initiated with a Neutral at BofA
Needham
Hold
Reiterated
11/17/25
Masimo's Legal Victory Against Apple: Hold Rating Amid Uncertainty and Potential DelaysWe expect Apple to file an appeal in the patent litigation case which we estimate could take 1.5 to 2 years to be resolved and delay MASI's collection of the $634M of damages. When and if MASI ultimately collects the damages, we expect it to use the cash for share repurchases and/or debt repayment.
Piper Sandler Analyst forecast on MASI
Piper Sandler
Piper Sandler
$105$210
Buy
47.74%
Upside
Reiterated
11/17/25
Analysts Offer Insights on Healthcare Companies: Teleflex (NYSE: TFX), Masimo (NASDAQ: MASI) and Pennant Group (NASDAQ: PNTG)
Stifel Nicolaus Analyst forecast on MASI
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterated
11/16/25
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (NASDAQ: STOK) and Masimo (NASDAQ: MASI)We would guesstimate that sometime in 1Q26 might be a reasonable assumption for the trade secrets ruling timing. That said, we also see no reason why the ruling couldn't come sooner given the extended time the trade secrets case has already taken. The case initially was heard in fall 2024. Once both official rulings are entered, Apple then would have 30 days to file an appeal. While we are not legal experts and do not have a full understanding of case precedence, all this suggests to us a possible early-to-mid 2027 timeline for the next Apple appeal decision. Our thinking here incorporates similar timing between the Philips and Nellcor initial jury verdicts and appeal decisions as a guide. However, MASI clearly indicated, unsurprisingly, that they do not believe there's any meritorious basis for Apple to succeed on appeal.
BTIG
$198
Buy
39.30%
Upside
Reiterated
11/16/25
Masimo's Legal Triumphs and Ongoing Battles with Apple Boost Buy RatingWe think the pendulum has clearly swung toward MASI in these legal fights. We think this may increase the chances of a positive resolution for MASI, whether a settlement between the two parties, a move to start negotiations, or some kind of monetary-based agreement. We expect MASI shares to move higher Monday as investors put the potential for a positive resolution back on the table. Our estimates are not under review. MASI will be hosting an Investor Day on Dec. 3.
TR | OpenAI - 4o Analyst forecast on MASI
TR | OpenAI - 4o
TR | OpenAI - 4o
$152$153
Hold
7.64%
Upside
Reiterated
11/05/25
AI Generated ArticleAI Generated Article
Wells Fargo Analyst forecast on MASI
Wells Fargo
Wells Fargo
$190
Buy
33.67%
Upside
Reiterated
08/15/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hyperfine (NASDAQ: HYPR), Molina Healthcare (NYSE: MOH) and Masimo (NASDAQ: MASI)Blood Oxygen Returns to U.S. Apple Watches; Patent Infringement Cases Carry More Weight, In Our View
Raymond James Analyst forecast on MASI
Raymond James
Raymond James
$185
Buy
30.15%
Upside
Reiterated
08/06/25
Masimo (MASI) Gets a Buy from Raymond James
Jefferies
$158$170
Hold
19.60%
Upside
Reiterated
08/06/25
Masimo (MASI) Receives a Hold from Jefferies
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on MASI
Bank of America Securities
Bank of America Securities
$162
Hold
13.97%
Upside
Initiated
11/17/25
Masimo initiated with a Neutral at BofAMasimo initiated with a Neutral at BofA
Needham
Hold
Reiterated
11/17/25
Masimo's Legal Victory Against Apple: Hold Rating Amid Uncertainty and Potential DelaysWe expect Apple to file an appeal in the patent litigation case which we estimate could take 1.5 to 2 years to be resolved and delay MASI's collection of the $634M of damages. When and if MASI ultimately collects the damages, we expect it to use the cash for share repurchases and/or debt repayment.
Piper Sandler Analyst forecast on MASI
Piper Sandler
Piper Sandler
$105$210
Buy
47.74%
Upside
Reiterated
11/17/25
Analysts Offer Insights on Healthcare Companies: Teleflex (NYSE: TFX), Masimo (NASDAQ: MASI) and Pennant Group (NASDAQ: PNTG)
Stifel Nicolaus Analyst forecast on MASI
Stifel Nicolaus
Stifel Nicolaus
Buy
Reiterated
11/16/25
Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (NASDAQ: STOK) and Masimo (NASDAQ: MASI)We would guesstimate that sometime in 1Q26 might be a reasonable assumption for the trade secrets ruling timing. That said, we also see no reason why the ruling couldn't come sooner given the extended time the trade secrets case has already taken. The case initially was heard in fall 2024. Once both official rulings are entered, Apple then would have 30 days to file an appeal. While we are not legal experts and do not have a full understanding of case precedence, all this suggests to us a possible early-to-mid 2027 timeline for the next Apple appeal decision. Our thinking here incorporates similar timing between the Philips and Nellcor initial jury verdicts and appeal decisions as a guide. However, MASI clearly indicated, unsurprisingly, that they do not believe there's any meritorious basis for Apple to succeed on appeal.
BTIG
$198
Buy
39.30%
Upside
Reiterated
11/16/25
Masimo's Legal Triumphs and Ongoing Battles with Apple Boost Buy RatingWe think the pendulum has clearly swung toward MASI in these legal fights. We think this may increase the chances of a positive resolution for MASI, whether a settlement between the two parties, a move to start negotiations, or some kind of monetary-based agreement. We expect MASI shares to move higher Monday as investors put the potential for a positive resolution back on the table. Our estimates are not under review. MASI will be hosting an Investor Day on Dec. 3.
TR | OpenAI - 4o Analyst forecast on MASI
TR | OpenAI - 4o
TR | OpenAI - 4o
$152$153
Hold
7.64%
Upside
Reiterated
11/05/25
AI Generated ArticleAI Generated Article
Wells Fargo Analyst forecast on MASI
Wells Fargo
Wells Fargo
$190
Buy
33.67%
Upside
Reiterated
08/15/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hyperfine (NASDAQ: HYPR), Molina Healthcare (NYSE: MOH) and Masimo (NASDAQ: MASI)Blood Oxygen Returns to U.S. Apple Watches; Patent Infringement Cases Carry More Weight, In Our View
Raymond James Analyst forecast on MASI
Raymond James
Raymond James
$185
Buy
30.15%
Upside
Reiterated
08/06/25
Masimo (MASI) Gets a Buy from Raymond James
Jefferies
$158$170
Hold
19.60%
Upside
Reiterated
08/06/25
Masimo (MASI) Receives a Hold from Jefferies
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Masimo

1 Month
xxx
Success Rate
20/31 ratings generated profit
65%
Average Return
+1.03%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 64.52% of your transactions generating a profit, with an average return of +1.03% per trade.
3 Months
xxx
Success Rate
16/31 ratings generated profit
52%
Average Return
+3.84%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 51.61% of your transactions generating a profit, with an average return of +3.84% per trade.
1 Year
Rick WiseStifel Nicolaus
Success Rate
21/31 ratings generated profit
68%
Average Return
+11.81%
reiterated a buy rating 6 days ago
Copying Rick Wise's trades and holding each position for 1 Year would result in 67.74% of your transactions generating a profit, with an average return of +11.81% per trade.
2 Years
xxx
Success Rate
24/30 ratings generated profit
80%
Average Return
+15.80%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.00% of your transactions generating a profit, with an average return of +15.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MASI Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
10
8
7
7
5
Hold
10
10
10
11
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
18
17
18
14
In the current month, MASI has received 5 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. MASI average Analyst price target in the past 3 months is 161.00.
Each month's total comprises the sum of three months' worth of ratings.

MASI Financial Forecast

MASI Earnings Forecast

Next quarter’s earnings estimate for MASI is $1.46 with a range of $1.44 to $1.50. The previous quarter’s EPS was $1.32. MASI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MASI has Performed in-line its overall industry.
Next quarter’s earnings estimate for MASI is $1.46 with a range of $1.44 to $1.50. The previous quarter’s EPS was $1.32. MASI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year MASI has Performed in-line its overall industry.

MASI Sales Forecast

Next quarter’s sales forecast for MASI is $407.36M with a range of $404.50M to $411.55M. The previous quarter’s sales results were $371.50M. MASI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MASI has Performed in-line its overall industry.
Next quarter’s sales forecast for MASI is $407.36M with a range of $404.50M to $411.55M. The previous quarter’s sales results were $371.50M. MASI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year MASI has Performed in-line its overall industry.

MASI Stock Forecast FAQ

What is MASI’s average 12-month price target, according to analysts?
Based on analyst ratings, Masimo Corp.’s 12-month average price target is 161.00.
    What is MASI’s upside potential, based on the analysts’ average price target?
    Masimo Corp. has 13.27% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MASI a Buy, Sell or Hold?
          Masimo Corp. has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Masimo Corp.’s price target?
            The average price target for Masimo Corp. is 161.00. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $198.00 ,the lowest forecast is $105.00. The average price target represents 13.27% Increase from the current price of $142.14.
              What do analysts say about Masimo Corp.?
              Masimo Corp.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of MASI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis